Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sheppard

Showing results (391-400 of 503) with videos related to

Pageof 51
Sort By:
Chemistry & Biology|January 25, 2008
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutationLuísa S Pissarra, Carlos M Farinha, Zhe Xu, et al.
Journal of the American College of Cardiology|March 13, 2024
RYR2 Variant and Sudden Death in Patients With Dilated CardiomyopathyYael Ben-Haim, Martin Bird, David Johnson, et al.
Osteoarthritis and Cartilage|February 6, 2022
The osteoarthritis bone score (OABS): a new histological scoring system for the characterisation of bone marrow lesions in osteoarthritisS Koushesh, S M Shahtaheri, D F McWilliams, et al.
Virchows Archiv : an International Journal of Pathology|March 19, 2021
Cardiac hypertrophy at autopsyCristina Basso, Katarzyna Michaud, Giulia d'Amati, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 11, 2019
Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTRSamuel J Bose, Marcel J C Bijvelds, Yiting Wang, et al.
British Journal of Pharmacology|June 7, 2014
CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTRYiting Wang, Jia Liu, Avgi Loizidou, et al.
Pharmacology Research & Perspectives|October 27, 2023
Experimental pharmacology in precision medicineAlicja Urbaniak, Kenneth E Thummel, Ayoade N Alade, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 15, 2021
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac deathGherardo Finocchiaro, Nabeel Sheikh, Ornella Leone, et al.
Journal of the American College of Cardiology|November 23, 2006
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathyRavi G Assomull, Sanjay K Prasad, Jonathan Lyne, et al.
Psychological Medicine|September 23, 1997
The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental originsA Lane, A Kinsella, P Murphy, et al.
Pageof 51

Showing results (391-400 of 503) with videos related to

Sort By:
Pageof 51
Chemistry & Biology|January 25, 2008
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutationLuísa S Pissarra, Carlos M Farinha, Zhe Xu, et al.
Journal of the American College of Cardiology|March 13, 2024
RYR2 Variant and Sudden Death in Patients With Dilated CardiomyopathyYael Ben-Haim, Martin Bird, David Johnson, et al.
Osteoarthritis and Cartilage|February 6, 2022
The osteoarthritis bone score (OABS): a new histological scoring system for the characterisation of bone marrow lesions in osteoarthritisS Koushesh, S M Shahtaheri, D F McWilliams, et al.
Virchows Archiv : an International Journal of Pathology|March 19, 2021
Cardiac hypertrophy at autopsyCristina Basso, Katarzyna Michaud, Giulia d'Amati, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 11, 2019
Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTRSamuel J Bose, Marcel J C Bijvelds, Yiting Wang, et al.
British Journal of Pharmacology|June 7, 2014
CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTRYiting Wang, Jia Liu, Avgi Loizidou, et al.
Pharmacology Research & Perspectives|October 27, 2023
Experimental pharmacology in precision medicineAlicja Urbaniak, Kenneth E Thummel, Ayoade N Alade, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 15, 2021
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac deathGherardo Finocchiaro, Nabeel Sheikh, Ornella Leone, et al.
Journal of the American College of Cardiology|November 23, 2006
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathyRavi G Assomull, Sanjay K Prasad, Jonathan Lyne, et al.
Psychological Medicine|September 23, 1997
The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental originsA Lane, A Kinsella, P Murphy, et al.
Pageof 51